miR-29a调控PER1-LAMR1相互作用影响放射后肺腺癌细胞侵袭迁移的研究

基本信息
批准号:81860536
项目类别:地区科学基金项目
资助金额:34.80
负责人:常莉
学科分类:
依托单位:昆明医科大学
批准年份:2018
结题年份:2022
起止时间:2019-01-01 - 2022-12-31
项目状态: 已结题
项目参与者:候宇,李岚,夏耀雄,王丽,李云芬,陈正庭,陈海霞,李蓉
关键词:
miR29a侵袭Per1放射肺腺癌
结项摘要

The circadian gene Per1 plays an important role on physiological function by protein-protein interaction. LAMR1 is one of the proteins interacted with PER1. Their combining site is coincide with the interacted site between LAMR1 and laminin which could regulate cell adhesion and invision. It is suggested that PER1 might interacted with LAMR1 competing with laminin, and the interaction intensity might influence the regulating ability of Per1 on tumor cell invasion and migration. Moreover, Per1 expression could be down-regulated by miR-29a which could affect cell proliferation and invasion of lung cancer. Per1 also could affect radiation killing of many kinds of tumor by influencing cell radiosensitivity. The previous study found that the migration of the residual lung adenocarcinoma cell A549 was changed after radiation follow the time. Therefore, the circadian gene Per1 is related with tumor invasion and metastasis, radiation, miR-29a and LAMR1; the invasion and metastasis of residual lung adenocarcinoma cell could changed after radiation. The study will focused on the change of cell invasion and migration of lung adenocarcinoma after radiation regulated by miR-29a through PER1-LAMR1 interaction mediated by Per1. The study will be help to illustrate the related mechanism of biological behavior change of lung adenocarcinoma cell after radiation.

节律基因Per1通过蛋白间相互作用发挥生理功能,LAMR1是其作用蛋白之一。其与PER1结合的位点恰与调控细胞粘附、侵袭的层粘连蛋白作用位点重合,提示PER1与层粘连蛋白竞争结合LAMR1,PER1-LAMR1相互作用强弱可能影响Per1对肿瘤细胞侵袭迁移等调控的能力。而Per1又可受到miR-29a调控表达下调,miR-29a本身也会影响肺癌细胞增殖侵袭。Per1还能影响多种肿瘤细胞对射线的敏感性,调控肿瘤放射杀灭。项目组前期发现,放射后残留肺腺癌A549细胞的迁移能力随时间延续发生不同改变。因此,结合节律基因Per1与肿瘤侵袭转移、放射、miR-29a及LAMR1的关系,以及放射后肺腺癌细胞侵袭转移的改变。本项目拟采用体内外实验研究miR-29a通过调控Per1表达介导PER1-LAMR1相互作用影响放射后肺腺癌细胞侵袭迁移能力的变化,以期揭示放射后肺腺癌细胞生物学行为变化的相关机制。

项目摘要

放射治疗是肺癌的主要治疗方法之一,但放疗后的复发转移却难以避免。节律基因Per1与肿瘤细胞增殖、侵袭、转移有关,并与可影响放射生物效应。本项目结合通过TPA刺激检测体外培养A549细胞后明确了细胞中Per1、miR-29a和LAMR1表达节律,并发现干扰Per1后A549细胞放射后侵袭、转移能力增强,MMP-2表达升高,而Per1过表达细胞放射后侵袭能力减弱。而转染 miR-29a mimics入A549细胞放射后侵袭、迁移能力减弱,Per1和MMP-2表达也降低;转染miR-29a inhibitor后结果相反。进一步通过回复实验发现miR-29a可抑制Per1表达,而二者均可抑制放射后肺腺癌细胞侵袭迁移。为探究其调控机制,将不同荧光蛋白标记的PER1和LAMR1过表达质粒共转染入A549细胞,再转染miR-29a mimics, X线照射。荧光共振能量转移检测发现PER1和LAMR1能够发生相互作用,转入miR-29a mimics后PER1-LAMR1作用减弱;PER1、LAMR1共转染细胞放射后侵袭能力减弱,而miR-29a、PER1、LAMR1三转染细胞的侵袭能力最弱;miR-29a可以影响Per1和LAMR1表达,转染了miR-29a、Per1、LAMR1的细胞MMP2、LN表达降低。构建肺腺癌裸鼠原位移植瘤模型,发现移植瘤组织中Per1、miR-29a表达呈现24h近日节律变化。分别在Per1表达峰值及谷值时间行8Gy X线胸部照射,活体荧光成像结果显示肿瘤生长延迟,Per峰值组差异较谷值组明显,Per1的表达变化也不同。研究提示miR-29a可能通过影响PER1、LAMR1的表达来调控PER1-LAMR1相互作用影响了放射后A549细胞的侵袭迁移能力。有助于探究肺腺癌放射生物学特性和行为,探索肺腺癌复发转移的防治策略,为肺癌的综合治疗疗效的提高提供理论指导。

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

MiR-145 inhibits human colorectal cancer cell migration and invasion via PAK4-dependent pathway

MiR-145 inhibits human colorectal cancer cell migration and invasion via PAK4-dependent pathway

DOI:10.1002/cam4.1029.
发表时间:2017
2

气载放射性碘采样测量方法研究进展

气载放射性碘采样测量方法研究进展

DOI:
发表时间:2020
3

Inhibiting miR-22 Alleviates Cardiac Dysfunction by Regulating Sirt1 in Septic Cardiomyopathy

Inhibiting miR-22 Alleviates Cardiac Dysfunction by Regulating Sirt1 in Septic Cardiomyopathy

DOI:10.3389/fcell.2021.650666
发表时间:2021
4

不同分子分型乳腺癌的多模态超声特征和临床病理对照研究

不同分子分型乳腺癌的多模态超声特征和临床病理对照研究

DOI:10.3760/cma.j.cn131148-20190926-00591
发表时间:2020
5

静脉血栓形成时间推断的法医学研究进展

静脉血栓形成时间推断的法医学研究进展

DOI:10.12116/j.issn.1004-5619.2019.02.008
发表时间:2019

相似国自然基金

1

PTTG1通过TGFβ1/SMAD3通路调控放射后肺腺癌细胞侵袭和免疫改变的研究

批准号:81660504
批准年份:2016
负责人:李文辉
学科分类:H1816
资助金额:37.00
项目类别:地区科学基金项目
2

两种肺腺癌细胞体内外放射后残留细胞增殖迁移及干细胞变化的比较性性研究

批准号:81560488
批准年份:2015
负责人:常莉
学科分类:H1816
资助金额:37.00
项目类别:地区科学基金项目
3

LncRNA Malat1调控miR-124影响肺腺癌细胞侵袭转移的机制研究

批准号:81702899
批准年份:2017
负责人:马腾
学科分类:H1809
资助金额:20.00
项目类别:青年科学基金项目
4

miR-29a参与胰岛素信号通路调控乳腺癌生长侵袭的机制研究

批准号:81260389
批准年份:2012
负责人:李志华
学科分类:H1802
资助金额:50.00
项目类别:地区科学基金项目